During his time at AnaptysBio, Hamza Suria held a substantial position in company stocks, peaking with approximately 418,864 shares. His insider trading activity revealed a trend of selling at significant highs, with notable transactions like selling shares worth around $2.44...

During his time at AnaptysBio, Hamza Suria held a substantial position in company stocks, peaking with approximately 418,864 shares. His insider trading activity revealed a trend of selling at significant highs, with notable transactions like selling shares worth around $2.44 million in November 2020. This reflects a savvy understanding of market dynamics, as his trading peaked amidst market interest in the company's therapies. After his resignation in March 2022, AnaPtysBio reported that he would still benefit from unvested equity awards during a consultancy arrangement. This flexible arrangement indicated a strong command over his exit strategy, making sure his financial interests aligned with the potential future performance of the company he once led.